DG

Devanshi Goswami

Active Director Director DIN 10165984
DIN 10165984 First appointment May 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value •••• Premium profile

About Devanshi Goswami

Data last updated:

Devanshi Goswami is a Director at Neorvana Healthcare Private Limited (since 2023). Neorvana Healthcare Private Limited reported revenue of ₹6.9 Lakh (FY 2025).

DIN 10165984
Primary Designation Director
First Appointment 16 May 2023
Oldest Company Age 3 yrs
Largest company Neorvana Healthcare Private Limited · ₹6.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Neorvana Healthcare Private Limited U46497DL2023PTC414259
Director16 May 20232023₹6.9 Lakh (FY 2025)Active

Board colleagues of Devanshi Goswami

Directorship timeline

Open interactive timeline →
Neorvana Healthcare Private Limited
Premium access

Shareholding and investment profile for Devanshi Goswami

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Devanshi Goswami

Devanshi Goswami currently holds 1 directorship: Neorvana Healthcare Private Limited (Director, since 16 May 2023, revenue ₹6.9 Lakh (FY 2025)).

Devanshi Goswami was first appointed on 16 May 2023 as Director at Neorvana Healthcare Private Limited.

The current boards of Devanshi Goswami's companies include Naveen Goswami (Neorvana Healthcare Private Limited), Vanshika Goswami (Neorvana Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available